Amgen says Phase 1 AMG 513 obesity study placed on clinical hold by FDA
Amgen (AMGN) provided updates on selected product and pipeline programs, including that a Phase 1 study of AMG 513 in people living with ...
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS
Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023.
ascopubs.org15d
Exploring the role of bispecific and CAR-T cell therapies in gastric cancer: A systematic review and meta-analysis.
Pembrolizumab or placebo plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) adenocarcinoma: An updated analysis of KEYNOTE-859 for patients enrolled in Asia.
C&EN23d
Bioinspired Nanofluidic Circuits with Integrating Excitatory and Inhibitory Synapses
Institute of Flexible Electronics (IFE, Future Technologies), Xiang’an Campus, Xiamen University, Xiang’an South Road, Xiamen 361102, Fujian, China State Key Laboratory of Physical Chemistry of Solid ...
BBC27d
Woman died after medics missed gastric band fault
A coroner has highlighted the "critical failure" in the care of a woman who died after a doctor failed to spot her gastric band had "slipped". Gemma Marshall died at Huddersfield Royal Infirmary ...